Apoptosis, fas and systemic autoimmunity: the MRL-Ipr/Ipr model
Authors:
Open Access
- 1 December 1994
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 6 (6) , 913-920
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Pharmacological inhibition of programmed lymphocyte deathImmunology Today, 1994
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994
- Effects of Early and Late Treatment with Anti-CD4 Monoclonal Antibody on Autoimmune Disease in MRL/MP-Ipr/Ipr MiceCellular Immunology, 1994
- T Cell Deletion in High Antigen Dose Therapy of Autoimmune EncephalomyelitisScience, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992
- Germinal centres in T-cell-dependent antibody responsesImmunology Today, 1992
- lnterleukin-2 programs mouse αβ T lymphocytes for apoptosisNature, 1991
- Induction by Antigen of Intrathymic Apoptosis of CD4 + CD8 + TCR lo Thymocytes in VivoScience, 1990